Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Finished Goods (2016 - 2025)

Utah Medical Products has reported Finished Goods over the past 15 years, most recently at $1.2 million for Q4 2025.

  • Quarterly results put Finished Goods at $1.2 million for Q4 2025, down 36.07% from a year ago — trailing twelve months through Dec 2025 was $1.2 million (down 36.07% YoY), and the annual figure for FY2025 was $1.2 million, down 36.07%.
  • Finished Goods for Q4 2025 was $1.2 million at Utah Medical Products, down from $1.9 million in the prior quarter.
  • Over the last five years, Finished Goods for UTMD hit a ceiling of $2.5 million in Q2 2023 and a floor of $1.1 million in Q2 2021.
  • Median Finished Goods over the past 5 years was $1.6 million (2024), compared with a mean of $1.7 million.
  • Biggest five-year swings in Finished Goods: soared 55.36% in 2023 and later crashed 47.06% in 2024.
  • Utah Medical Products' Finished Goods stood at $1.5 million in 2021, then rose by 29.16% to $1.9 million in 2022, then fell by 11.13% to $1.7 million in 2023, then grew by 13.53% to $1.9 million in 2024, then plummeted by 36.07% to $1.2 million in 2025.
  • The last three reported values for Finished Goods were $1.2 million (Q4 2025), $1.9 million (Q4 2024), and $1.4 million (Q3 2024) per Business Quant data.